Ultragenyx Pharmaceutical, Inc. (RARE)

34.74 +1.24 (+3.72%) USD  |  NASDAQ  |  Dec 22, 16:00
34.70 -0.04 (-0.13%) After-Hours: 20:00
More

Ultragenyx Pharmaceutical EPS Diluted from Continuing Operations (Quarterly)

EPS Diluted from Continuing Operations (Quarterly) Chart

View EPS Diluted from Continuing Operations (Quarterly) for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Continuing Operations (Quarterly) Benchmarks

View EPS Diluted from Continuing Operations (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade